Carlsmed launches Aprevo platform for cervical fusion surgeries

Carlsmed (Nasdaq:CARL) announced today that it began the U.S. launch of its Aprevo technology platform for cervical fusion surgeries.

Aprevo expands Carlsmed’s personalized spine platform, which combines AI-driven preoperative planning with 3D-printed, patient-specific implants tailored to each patient’s anatomy and pathology. The company said it builds upon the success of its Aprevo lumbar platform.

Carlsbad, California–based Carlsmed designed the Aprevo devices to match the unique anatomical and alignment needs of each patient. The company’s proprietary AI-powered surgical planning platform and digital production system power the devices.

Sign up for Blog Updates